What is nitroglycerin used for? Nitroglycerin is commonly used to treat and prevent chest pain caused by a type of heart disease (coronary artery disease). Nitroglycerin may also be used for other ...
Product: Nitroglycerin 0.4 MG/ACT sprays and Nitrostat 0.3mg/0.6mg sublingual tablets (added on May 10, 2023) What to do: Speak with your healthcare professional about how best to manage any impact of ...
GoNitro Espero announced the launch of GoNitro (nitroglycerin) sublingual powder for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease. Espero announced the ...
GoNitro Espero announced that the Food and Drug Administration (FDA) has approved GoNitro (nitroglycerin) sublingual powder for acute relief of an attack or prophylaxis of angina pectoris due to ...
A spray used to help Canadians suffering from angina, a type of chest pain caused by reduced blood flow to the heart, is in short supply and may dry up in the near future, according to experts. Health ...
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Espero Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved ...
OTTAWA Health Canada is advising consumers that Mylan Pharmaceuticals ULC has begun a voluntary recall of certain lots of a nitroglycerin heart medication from retailers. Some lots of the product, ...
Dr Reddy’s Laboratories today said it has launched nitroglycerin sublingual tablets, a therapeutic equivalent generic version of Nitrostat (Nitroglycerin) sublingual tablets in the US. The drug which ...
The Nitrostat (nitroglycerin) sublingual tablet brand had US sales of approximately $108 million MAT for the most recent twelve months ending in March 2016 Dr Reddy’s Laboratories (DRL) has launched ...
Pune, Maharashtra, November 14 2022 (Wiredrelease) Market.Biz –:Global Medical Nitroglycerin Spray Market report provides a holistic assessment of the worldwide and regional market for the forecast ...
According to Future Market Insights (FMI), the global medical nitroglycerin sprays market was valued at US$ 94.4 Mn in 2019, and is expected to register a CAGR of 4.2% during the forecast period, ...
Dr. Reddy’s Laboratories Ltd has launched Nitroglycerin sublingual tablets USP, 0.3 mg, 0.4 mg and 0.6 mg, a therapeutic equivalent generic version of Nitrostat (Nitroglycerin) sublingual tablets in ...